NUVIG · NVG-2089-201
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). EU CT 2024-515386-34-00
Sponsor: Nuvig Therapeutics
Phase: II
Area: Neuromuscular disorders